Mandate

Vinge advises in conjunction with the sale of Astrego Diagnostics to Sysmex

May 02, 2022 M&A

Vinge has advised the main owners of Astrego Diagnostics AB in conjunction with the sale of the shares to the Japanese minority owner, Sysmex Corporation.

Astrego has developed a diagnostic tool for determining the presence of bacteria in patient samples and the determination of resistance against different antibiotics (so-called ”Antibiotic Susceptibility Test, AST”).

Vinge’s team consisted of Johan WinnerbladEléonore FribergViktoria Owetz Leyva and Gunilla Nyman.

Related

Vinge has advised Embracer Group in connection with a EUR 900 million bridge facility agreement entered into with JP Morgan, BNP Paribas, SEB, Société Générale and Swedbank

Vinge has advised Embracer Group AB (publ) (“Embracer”) and its subsidiary group Asmodee in connection with the entry into of a EUR 900,000,000 financing agreement with JP Morgan, BNP Paribas, SEB, Société Générale and Swedbank and concurrent prepayment of existing Embracer indebtedness.
April 22, 2024

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024